<code id='7C024D6105'></code><style id='7C024D6105'></style>
    • <acronym id='7C024D6105'></acronym>
      <center id='7C024D6105'><center id='7C024D6105'><tfoot id='7C024D6105'></tfoot></center><abbr id='7C024D6105'><dir id='7C024D6105'><tfoot id='7C024D6105'></tfoot><noframes id='7C024D6105'>

    • <optgroup id='7C024D6105'><strike id='7C024D6105'><sup id='7C024D6105'></sup></strike><code id='7C024D6105'></code></optgroup>
        1. <b id='7C024D6105'><label id='7C024D6105'><select id='7C024D6105'><dt id='7C024D6105'><span id='7C024D6105'></span></dt></select></label></b><u id='7C024D6105'></u>
          <i id='7C024D6105'><strike id='7C024D6105'><tt id='7C024D6105'><pre id='7C024D6105'></pre></tt></strike></i>

          focus

          focus

          author:focus    Page View:6
          Photo of a doctor holding a cellphone. -- first opinion coverage from STAT
          Adobe

          Thinking about messaging your physician about a weird rash? You may want to hold off on it. Some hospital systems have started charging patients for digital messages to their doctors via the electronic medical record, either a flat rate (like a copay) or on sliding scale depending on the time or complexity of the physician’s response. Sometimes it’s billed through an insurer, sometimes as a direct cost to the patient. Costs have ranged between less than $10 and $100 for a message.

          Now that at least 22 hospital systems have implemented the practice, a great debate has broken out in the medical profession: Is charging patients to send a note to a doctor just common sense or an unjust expense?

          advertisement

          In asking family, friends, and colleagues about this, my grandmother’s response was the most enlightening: “I’m surprised doctors ever stopped charging for phone calls!”

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          leisure time

          FDA approval of Sarepta Duchenne genetic therapy gives me hope
          FDA approval of Sarepta Duchenne genetic therapy gives me hope

          Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

          read more
          Gilead acquiring CymaBay and its liver disease drug for $4.3 billion
          Gilead acquiring CymaBay and its liver disease drug for $4.3 billion

          YichuanCao/SipaUSAGileadSciencessaidMondayitwillacquireCymaBayTherapeuticsfor$4.3billion,addinganewt

          read more
          BioMarin wins approval for gene therapy to treat hemophilia A
          BioMarin wins approval for gene therapy to treat hemophilia A

          AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

          read more

          What we’ve learned from the Aduhelm mess

          MollyFergusonforSTATSTATnowpublishesselectedLetterstotheEditorreceivedinresponsetoFirstOpinionessays